Showing results (21-30 of 259) with videos related to
Sort By:
Pageof 26
Chest|November 25, 2005
Ventilator-associated pneumonia: insights from recent clinical trialsAndrew F Shorr, Marin H KollefBMC Health Services Research|November 27, 2008
Prolonged acute mechanical ventilation and hospital bed utilization in 2020 in the United States: implications for budgets, plant and personnel planningMarya D Zilberberg, Andrew F ShorrAmerican Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 9, 2009
Guidelines and quality for community-acquired pneumonia: measures from the Joint Commission and the Centers for Medicare and Medicaid ServicesAndrew F Shorr, Robert C OwensCurrent Opinion in Pulmonary Medicine|March 13, 2015
Role for risk-scoring tools in identifying resistant pathogens in pneumonia: reassessing the value of healthcare-associated pneumonia as a conceptAndrew F Shorr, Marya D ZilberbergSeminars in Respiratory and Critical Care Medicine|August 10, 2012
Economics at the end of life: hospital and ICU perspectivesMarya D Zilberberg, Andrew F ShorrExpert Opinion on Pharmacotherapy|March 25, 2021
Issues in antibiotic therapy for hospital-acquired and ventilator-associated pneumonia: emerging concepts to improve outcomesSyed Nazeer Mahmood, Andrew F ShorrChest|April 12, 2002
Ethical assessment of industry-sponsored clinical trials: a case analysisFranklin G Miller, Andrew F ShorrAmerican Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 9, 2009
Rational dosing of antimicrobial agents: pharmacokinetic and pharmacodynamic strategiesRobert C Owens, Andrew F ShorrInfectious Disease Clinics of North America|August 12, 2009
Fungal infections in the ICUMarya D Zilberberg, Andrew F ShorrCurrent Opinion in Infectious Diseases|May 19, 2011
Ventilator-associated pneumonia as a model for approaching cost-effectiveness and infection prevention in the ICUMarya D Zilberberg, Andrew F ShorrPageof 26